Literatur
-
1
Berneis K, Rizzo M, Berthold H K, Spinas G A, Krone W, Gouni-Berthold I.
Ezetimibe alone
or in combination with simvastatin increases small dense low-density
lipoproteins in healthy men: a randomized trial.
Europ
Heart J.
DOI: 10.1093/eurheartj/ehq181
-
2
Bruckert E, Labreuche J, Amarenco P.
Meta-analysis of the effect of nicotinic acid alone or in combination
on cardiovascular events and atherosclerosis.
Atherosclerosis.
2010;
210
353-361
-
3
Buchwald H, Varco R L, Boen J R. et al .
Effective Lipid Modification
by Partial Ileal Bypass reduced Long-term Coronary Heart Disease Mortality
and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH.
Arch Intern Med.
1998;
158
1253-1261
-
4
Delahoy P J, Magliano D J, Webb K, Grobler M, Liew D.
The Relationship Between Reduction in Low-Density Lipoprotein
Cholesterol by Statins and Reduction in Risk of Cardiovascular Outcomes:
An Updated Meta-Analysis.
Clin Ther.
2009;
31
236-244
-
5
Frost R JA, Otto C, Geiss H C, Schwandt P, Parhofer K G.
Effects of Atorvastatin Versus Fenofibrate on Lipoprotein Profiles,
Low-Density Lipoprotein Subfraction Distribution, and Hemorheologic
Parameters in Type 2 Diabetes Mellitus With Mixed Hyperlipoproteinemia.
Am J Cardiol.
2001;
87
44-48
-
6
Holme I, Boman K, Brudi P. et
al .
Observed and Predicted Reduction of Ischemic Cardiovascular
Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial.
Am J Cardiol.
2010;
105
1802-1808
-
7
Kastelein J JP, Akdim F, Stroes E SG.
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia.
N Engl J Med.
2008;
358
1431-1443
-
8
Keech A, Simes R J, Barter P. et al .
Effects of long-term fenofibrate therapy
on cardiovascular events in 9795 people with type 2 diabetes mellitus
(the FIELD study): randomised controlled trial.
Lancet.
2005;
366
1849-1861
-
9
Lemieux I, Laperriere L, Dzavik V, Tremblay G, Bourgeois J, Despres J P.
A 16-week
fenofibrate treatment increases LDL particle size in type IIA dyslipidemic
patients.
Atherosclerosis.
2002;
162
363-371
-
10
Probstfield J L, Rifkind B M.
The Lipid
Research Clinics Coronary Primary Prevention Trial: design, results
and implications.
Eur J Clin Pharmacol.
1991;
40
(Suppl. 1)
S69-S75
-
11
Taylor A J, Villines T C, Stanek E J. et al .
Extended-release niacin
or ezetimibe and carotid intima-media thickness.
N Engl
J Med.
2009;
361
2113-2122
-
12
The ACCORD Study Group .
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus.
N Engl J Med.
2010;
362
1563-74
-
13
Villines T C, Stanek E J, Devine P J. et al .
The ARBITER 6-HALTS Trial
(Arterial Biology for the Investigation of the Treatment Effects
of Reducing Cholesterol 6 – HDL and LDL Treatment Strategies
in Atherosclerosis).
J Am Coll Cardiol.
2010;
55
2721-2726
-
14
Erdmann E.
Zur aktuellen Debatte über die Senkung des LDL-Cholesterins
durch Ezetimib.
Dtsch Med Wochenschr.
2010;
135
1742
Prof. Dr. med. H.-W. M. Breuer
Malteser Krankenhaus St. Carolus Görlitz
Carolusstr. 212
02827 Görlitz
Phone: 03581721002
Fax: 03581721003
Email: hwm.breuer@malteser.org
